NEW YORK (GenomeWeb News) – Rosetta Genomics will work with the National Institutes of Health to discover microRNAs that may be involved in the viral replication of HIV, the company said today.
Rosetta said it will tap into its microRNA intellectual property and technologies, as well as publicly known human and viral microRNAs, to find out how microRNAs are involved in viral replication in HIV infections and the life cycle of the disease, and whether they may be used as potential novel drug targets for the disease.
The company cited a study published last year in Nature Medicine that showed that microRNAs are involved in suppressing HIV replication and keeping it latent.
Financial terms of the agreement were not released.